CHILDRENS HOSPITAL LOS ANGELES
Patent Owner
Stats
- 29 US PATENTS IN FORCE
- 9 US APPLICATIONS PENDING
- Mar 06, 2018 most recent publication
Details
- 29 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,252 Total Citation Count
- May 19, 1989 Earliest Filing
- 39 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0188,886 METHOD, SYSTEM AND SOFTWARE FOR ASSESSING EXTUBATION FAILUREMay 28, 15Jul 06, 17[A61B, G06F]
2016/0317,619 USE OF NEUREGULIN-4 FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND NECROTIZING ENTEROCOLITISApr 26, 16Nov 03, 16[A61K, G01N]
2016/0166,192 MAGNETIC RESONANCE IMAGING TOOL TO DETECT CLINICAL DIFFERENCE IN BRAIN ANATOMYJul 30, 14Jun 16, 16[A61B]
2016/0017,318 GENE SIGNATURES TO IDENTIFY MOLECULAR SUBGROUPS IN MEDULLOBLASTOMA TUMORSJul 21, 15Jan 21, 16[C12N]
2011/0256,110 AMNIOTIC FLUID CELLS AND USES THEREOFOct 23, 09Oct 20, 11[A61K, C12Q, C12N, G01N, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9580451 Sulfonic esters of metal oxides and methods of their useJan 26, 15Feb 28, 17[A61K, C07F, C07D]
9352023 Use of neuregulin-4 for treatment of inflammatory bowel disease and necrotizing enterocolitisAug 15, 12May 31, 16[A61K]
9353366 Asparaginase and treating diseases associated with asparagine dependenceMay 07, 15May 31, 16[A61K, C12N]
9173590 Method and system for quantitative renal assessmentMay 17, 11Nov 03, 15[A61K, G06T, A61B, A61M]
9051561 Asparaginase and treating diseases associated with asparagine dependenceOct 09, 12Jun 09, 15[A61K, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0081,110 ELECTROPHYSIOLOGICAL DIAGNOSIS AND TREATMENT FOR ASTHMAAbandonedJun 04, 12Mar 20, 14[A61B, A61N]
2012/0196,760 METHODS AND COMPOSITIONS FOR IDENTIFYING MODULATORS OF ANTI-TETHERIN ACTIVITY TO INHIBIT PROPAGATION OF VIRUSESAbandonedSep 04, 09Aug 02, 12[C12Q, C12N, C40B, C07K]
2012/0039,858 METHODS AND COMPOSITIONS FOR INHIBITING PROPAGATION OF VIRUSES USING RECOMBINANT TETHERIN CONSTRUCTSAbandonedOct 16, 09Feb 16, 12[A61K, C07H, C12N, A61P, C07K]
2011/0212,858 SYNTHETIC POLY D/L LYSINE FOR CONTROL OF DIRECTION AND RATE OF NEURITE GROWTH AND REGENERATIONAbandonedNov 13, 09Sep 01, 11[C12N, C40B]
2010/0311,765 METABOLIC DEGRADATION INHIBITORS FOR ANTI-HYPERPROLIFERATIVE AGENTSAbandonedSep 26, 08Dec 09, 10[A61K, A61P]
2010/0035,911 DRUG COMBINATIONS TO TREAT HYPERPROLIFERATIVE DISORDERSAbandonedMay 16, 07Feb 11, 10[A61K, A61P]
7537757 Methods of facilitating vascular growth in cardiac muscle and methods for the production of recombinant EMAP IIExpiredDec 08, 00May 26, 09[A61K, C07K]
7398119 Assessing blood brain barrier dynamics or identifying or measuring selected substances, including ethanol or toxins, in a subject by analyzing Raman spectrum signalsExpiredMar 25, 03Jul 08, 08[A61B]
7264803 Methods and pharmaceutical formulations for the treatment of pulmonary hypertensionExpiredOct 21, 02Sep 04, 07[A61K]
6991788 Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependenceExpiredJan 21, 03Jan 31, 06[A61K]
6984379 Gene therapy by administration of genetically engineered CD34+ cells obtained from cord bloodExpiredApr 08, 94Jan 10, 06[A61K, C12N]
2005/0261,779 Expansible rod-type prosthesis and external magnetic apparatusAbandonedNov 17, 03Nov 24, 05[A61F, A61B]
6961599 Identifying or measuring selected substances or toxins in a subject using resonant raman signalsExpiredMar 25, 03Nov 01, 05[A61B]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.